ONYX PHARMACEUTICALS INC Selling, General and Administrative Expense
ONYX PHARMACEUTICALS INC reported Selling, General and Administrative Expense of $87.51 million for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2013-08-09
- ONYX PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2013-06-30 was $87.51M, a 78.94% increase year-over-year.
- ONYX PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2013-03-31 was $72.55M, a 86.28% increase year-over-year.
- ONYX PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2012-12-31 was $74.57M, a 41.73% increase year-over-year.
- ONYX PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2012-09-30 was $61.75M, a 44.80% increase year-over-year.
- ONYX PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2012 was $224.16M, a 33.46% increase from fiscal 2011.
- ONYX PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2011 was $167.96M, a 47.12% increase from fiscal 2010.
- ONYX PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2010 was $114.17M, a 12.89% increase from fiscal 2009.
- ONYX PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2009 was $101.13M, a 24.86% increase from fiscal 2008.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2013-06-30 | $87.51M 10-Q · filed 2013-08-09 | $160.06M 10-Q · filed 2013-08-09 | $234.62M derived: sum of 3 quarters · filed 2013-08-09 | $296.37M derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | $72.55M 10-Q · filed 2013-05-08 | $147.11M derived: sum of 2 quarters · filed 2013-05-08 | $208.86M derived: sum of 3 quarters · filed 2013-05-08 | $257.76M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-12-31 | $74.57M 10-K · filed 2013-02-28 | $136.31M derived: sum of 2 quarters · filed 2013-02-28 | $185.22M derived: sum of 3 quarters · filed 2013-08-09 | $224.16M 10-K · filed 2013-02-28 |
| 2012-09-30 | $61.75M 10-K · filed 2013-02-28 | $110.65M derived: sum of 2 quarters · filed 2013-08-09 | $149.60M 10-Q · filed 2012-11-02 | $202.21M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-06-30 | $48.91M 10-Q · filed 2013-08-09 | $87.85M 10-Q · filed 2013-08-09 | $140.46M derived: sum of 3 quarters · filed 2013-08-09 | $183.10M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-03-31 | $38.94M 10-Q · filed 2013-05-08 | $91.56M derived: sum of 2 quarters · filed 2013-05-08 | $134.20M derived: sum of 3 quarters · filed 2013-05-08 | $172.43M derived: sum of 4 quarters · filed 2013-05-08 |
| 2011-12-31 | $52.61M 10-K · filed 2013-02-28 | $95.25M derived: sum of 2 quarters · filed 2013-02-28 | $133.49M derived: sum of 3 quarters · filed 2013-02-28 | $167.96M 10-K · filed 2013-02-28 |
| 2011-09-30 | $42.64M 10-K · filed 2013-02-28 | $80.88M derived: sum of 2 quarters · filed 2013-02-28 | $115.35M 10-Q · filed 2012-11-02 | $152.22M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | $38.24M 10-K · filed 2013-02-28 | $72.71M 10-Q · filed 2012-08-06 | $109.58M derived: sum of 3 quarters · filed 2013-02-28 | $135.51M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | $34.47M 10-K · filed 2013-02-28 | $71.35M derived: sum of 2 quarters · filed 2013-02-28 | $97.27M derived: sum of 3 quarters · filed 2013-02-28 | $123.92M derived: sum of 4 quarters · filed 2013-02-28 |
| 2010-12-31 | $36.88M 10-K · filed 2012-02-27 | $62.80M derived: sum of 2 quarters · filed 2012-02-27 | $89.45M derived: sum of 3 quarters · filed 2012-02-27 | $114.17M 10-K · filed 2013-02-28 |
| 2010-09-30 | $25.92M 10-K · filed 2012-02-27 | $52.57M derived: sum of 2 quarters · filed 2012-02-27 | $77.29M 10-Q · filed 2011-11-03 | $109.53M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-06-30 | $26.65M 10-K · filed 2012-02-27 | $51.37M 10-Q · filed 2011-08-09 | $83.60M derived: sum of 3 quarters · filed 2012-02-27 | $107.04M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-03-31 | $24.72M 10-K · filed 2012-02-27 | $56.95M derived: sum of 2 quarters · filed 2012-02-27 | $80.39M derived: sum of 3 quarters · filed 2012-02-27 | $103.90M derived: sum of 4 quarters · filed 2012-02-27 |
| 2009-12-31 | $32.23M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $55.67M derived: sum of 2 quarters · filed 2012-02-27 | $79.18M derived: sum of 3 quarters · filed 2012-02-27 | $101.13M 10-K · filed 2012-02-27 |
| 2009-09-30 | $23.44M 10-Q · filed 2010-11-03 | $46.95M derived: sum of 2 quarters · filed 2010-11-03 | $68.90M 10-Q · filed 2010-11-03 | |
| 2009-06-30 | $23.51M 10-Q · filed 2010-08-04 | $45.46M 10-Q · filed 2010-08-04 | ||
| 2008-12-31 | $80.99M 10-K · filed 2011-02-23 |